Opening GPAtlas…

🌊 The Ocean Library · GP clinical topic

Type 1 Diabetes & Insulin therapy (T1DM)

Reviewed and updated by practising UK GPs, overseen by our Clinical Advisory Officer. Last updated 29 Aug 2026.

🧭 When to suspect

Type 1 diabetes is an autoimmune condition in which the pancreatic beta cells are destroyed, leaving the body unable to produce insulin. It accounts for roughly 5–10% of all diabetes.

Incidence peaks in puberty and early adulthood, but new-onset type 1 diabetes can occur at any age – so it must never be excluded on age alone.

In a child or young person, suspect type 1 diabetes when hyperglycaemia presents with the classic "4 Ts":

• Thirst (polydipsia)

• Toilet (polyuria)

• Tired (lethargy)

• Thinner (unexplained weight loss)

In an adult, suspect it when hyperglycaemia is accompanied by:

• Ketosis

• Rapid weight loss

• Onset under 50 years

• BMI < 25 kg/m²

• A personal or family history of autoimmune disease

Apply these while remembering that age and BMI must not be used in isolation to diagnose or exclude it. Blurred vision and recurrent infection (thrush, periodontitis) are common early clues.

• Be alert that, in children, a large minority – around a quarter to over a third in UK audit data – first present in diabetic ketoacidosis rather than with the gradual 4 Ts, with the highest rates in the under-5s, who depend on carers to notice the symptoms.

• A new childhood diagnosis is therefore frequently a medical emergency, and delayed recognition is the single biggest avoidable harm.

Conversely, not every young person with diabetes has type 1. Consider monogenic diabetes (MODY), which is commonly mislabelled as type 1:

• Autosomal dominant, non-ketotic, antibody-negative, with preserved C-peptide and a strong multi-generational family history

• The HNF1A and HNF4A subtypes are sulfonylurea-sensitive (some can come off insulin) and GCK MODY usually needs no treatment

• Refer atypical cases for genetic testing rather than committing them to lifelong insulin

The two priorities in primary care are:

• Act on the emergencies – suspect diabetic ketoacidosis (DKA) whenever there is nausea, vomiting, abdominal pain or deep sighing (Kussmaul) breathing

• In those already on insulin, recognise and pre-empt hypoglycaemia and impaired hypoglycaemia awareness

Diagnostic test Supports a diagnosis of diabetes
Random plasma glucose (with symptoms) > 11.1 mmol/L
Fasting plasma glucose ≥ 7.0 mmol/L
HbA1c ≥ 48 mmol/mol (6.5%) confirms diabetes – but do not rely on HbA1c to diagnose or exclude type 1: a normal value does not exclude rapidly developing disease, and treatment must never be delayed awaiting it.

⚠️ Common pitfall

• Anchoring on type 2 diabetes in a slim or older adult and reaching for metformin.

• Type 1 diabetes (and slowly-evolving latent autoimmune diabetes in adults [LADA]) presents across the age range.

• Age or BMI alone must never decide the type.

• If there is ketosis or rapid weight loss, treat as type 1, start the same-day referral pathway, and do not withhold insulin.

Hyperglycaemia: could this betype 1?•child: the 4 Ts - Thirst, Toilet, Tired,Thinner•adult: ketosis, rapid weight loss, onsetunder 50, BMI < 25, or personal/familyautoimmune disease•never exclude type 1 on age aloneDKA features?nausea, vomiting, abdominal pain,Kussmaul breathing, dehydration,drowsiness; around a quarter to over athird of children first present in DKA(highest in the under-5s)Emergency admission: IV fluidsand IV insulinsevere hypoglycaemia: IM glucagon or IVglucose and 999Diagnostic thresholdsRandom plasma glucose >11.1 mmol/L (withsymptoms)supports diabetesFasting plasma glucose ≥7.0 mmol/Lsupports diabetesHbA1c ≥ 48 mmol/mol(6.5%)confirms diabetes - but never relyon it to exclude type 1Urine ketones ≥ 2+ orblood ketones ≥ 3 mmol/Ladmit immediately if elevated withintercurrent illnessTwo or moreautoantibodies (GAD,IA-2, ZnT8, IAA, ICA)specialist: differentiates type 1where uncertainDon't anchor on type 2 in aslim or older adult•age or BMI alone must never decide thetype•ketosis or rapid weight loss: treat astype 1, start same-day referral, do notwithhold insulin•LADA presents across the age rangeSame-day specialist diabetesteam referral•insulin is specialist-initiated in type1, never de novo in primary care•MDI basal-bolus first-line: twice-dailydetemir (Levemir, ending Dec 2026)•alternatives glargine (Lantus,Abasaglar), degludec (Tresiba)•bolus aspart (NovoRapid, Fiasp), lispro(Humalog)Atypical: consider monogenicdiabetes (MODY)•autosomal dominant, non-ketotic,antibody-negative, preserved•C-peptide, strong multi-generationalfamily history•HNF1A/HNF4A are sulfonylurea-sensitive;GCK usually untreated•refer for genetic testing, not lifelonginsulinGP shared care thereafter•structured education (DAFNE) 6-12 monthsafter diagnosis•never stop insulin: sick-day rules,glucose 1-2 hourly, ketones•3-4 hourly; annual eye screening from12, foot check, urine ACR•aged 60 or over with new diabetes andweight loss: consider pancreatic cancerYEStype 1 likelyantibody-negative, atypicalNONever decide the type on ageOcean 🌊GPAtlas Ocean 🌊

Source: NICE NG17 · NICE NG18


🔒 Sign up free to read the full topic

You're viewing a free preview. Create a free account to unlock the rest.

Sign up free →
Inside the full topic 🔒 History🔒 Red Flags🔒 Examination🔒 Patient Explanation🔒 Investigations🔒 Management🔒 Non-pharmacological Treatment🔒 Pharmacological Treatment🔒 Special Notes & DVLA🔒 Referral Pathways🔒 Take Home Messages

Sample topics are open to everyone in the Free Sample Bundle.

Part of The Ocean Library, 450+ structured clinical topics mapped to the primary care curriculum. Companion audio in Echo · one-page summary in The Scope.

We use cookies to enhance your browsing experience, provide personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Privacy policy